Safety and Immunogenicity Study of Three mRNAs Encoding HIV Immunogens in Adult Participants Without HIV and in Overall Good Health in South Africa.
Clinical trial NCT06694753 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06694753
- Sponsor
- International AIDS Vaccine Initiative
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-15
- Primary completion
- 2026-12-08
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.